Perspective

A dynamics-based classification of ventricular arrhythmias

James N. Weiss, Alan Garfinkel, Hrayr S. Karagueuzian, Thao P. Nguyen, Riccardo Olcese, Peng-Sheng Chen, Zhilin Qu

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Despite key advances in the clinical management of life-threatening ventricular arrhythmias, culminating with the development of implantable cardioverter-defibrillators and catheter ablation techniques, pharmacologic/biologic therapeutics have lagged behind. The fundamental issue is that biological targets are molecular factors. Diseases, however, represent emergent properties at the scale of the organism that result from dynamic interactions between multiple constantly changing molecular factors. For a pharmacologic/biologic therapy to be effective, it must target the dynamic processes that underlie the disease. Here we propose a classification of ventricular arrhythmias that is based on our current understanding of the dynamics occurring at the subcellular, cellular, tissue and organism scales, which cause arrhythmias by simultaneously generating arrhythmia triggers and exacerbating tissue vulnerability. The goal is to create a framework that systematically links these key dynamic factors together with fixed factors (structural and electrophysiological heterogeneity) synergistically promoting electrical dispersion and increased arrhythmia risk to molecular factors that can serve as biological targets. We classify ventricular arrhythmias into three primary dynamic categories related generally to unstable Ca cycling, reduced repolarization, and excess repolarization, respectively. The clinical syndromes, arrhythmia mechanisms, dynamic factors and what is known about their molecular counterparts are discussed. Based on this framework, we propose a computational-experimental strategy for exploring the links between molecular factors, fixed factors and dynamic factors that underlie life-threatening ventricular arrhythmias. The ultimate objective is to facilitate drug development by creating an in silico platform to evaluate and predict comprehensively how molecular interventions affect not only a single targeted arrhythmia, but all primary arrhythmia dynamics categories as well as normal cardiac excitation-contraction coupling.

Original languageEnglish (US)
Pages (from-to)136-152
Number of pages17
JournalJournal of Molecular and Cellular Cardiology
Volume82
DOIs
StatePublished - May 1 2015

Fingerprint

Cardiac Arrhythmias
Ablation Techniques
Excitation Contraction Coupling
Biological Therapy
Indwelling Catheters
Catheter Ablation
Implantable Defibrillators
Biological Products
Computer Simulation
Pharmaceutical Preparations

Keywords

  • Ca signaling
  • Fibrillation
  • Nonlinear dynamics
  • Reentry
  • Repolarization reserve
  • Sudden cardiac death

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Perspective : A dynamics-based classification of ventricular arrhythmias. / Weiss, James N.; Garfinkel, Alan; Karagueuzian, Hrayr S.; Nguyen, Thao P.; Olcese, Riccardo; Chen, Peng-Sheng; Qu, Zhilin.

In: Journal of Molecular and Cellular Cardiology, Vol. 82, 01.05.2015, p. 136-152.

Research output: Contribution to journalArticle

Weiss, James N. ; Garfinkel, Alan ; Karagueuzian, Hrayr S. ; Nguyen, Thao P. ; Olcese, Riccardo ; Chen, Peng-Sheng ; Qu, Zhilin. / Perspective : A dynamics-based classification of ventricular arrhythmias. In: Journal of Molecular and Cellular Cardiology. 2015 ; Vol. 82. pp. 136-152.
@article{25e81b99ec1843a2889b6b17e17b48af,
title = "Perspective: A dynamics-based classification of ventricular arrhythmias",
abstract = "Despite key advances in the clinical management of life-threatening ventricular arrhythmias, culminating with the development of implantable cardioverter-defibrillators and catheter ablation techniques, pharmacologic/biologic therapeutics have lagged behind. The fundamental issue is that biological targets are molecular factors. Diseases, however, represent emergent properties at the scale of the organism that result from dynamic interactions between multiple constantly changing molecular factors. For a pharmacologic/biologic therapy to be effective, it must target the dynamic processes that underlie the disease. Here we propose a classification of ventricular arrhythmias that is based on our current understanding of the dynamics occurring at the subcellular, cellular, tissue and organism scales, which cause arrhythmias by simultaneously generating arrhythmia triggers and exacerbating tissue vulnerability. The goal is to create a framework that systematically links these key dynamic factors together with fixed factors (structural and electrophysiological heterogeneity) synergistically promoting electrical dispersion and increased arrhythmia risk to molecular factors that can serve as biological targets. We classify ventricular arrhythmias into three primary dynamic categories related generally to unstable Ca cycling, reduced repolarization, and excess repolarization, respectively. The clinical syndromes, arrhythmia mechanisms, dynamic factors and what is known about their molecular counterparts are discussed. Based on this framework, we propose a computational-experimental strategy for exploring the links between molecular factors, fixed factors and dynamic factors that underlie life-threatening ventricular arrhythmias. The ultimate objective is to facilitate drug development by creating an in silico platform to evaluate and predict comprehensively how molecular interventions affect not only a single targeted arrhythmia, but all primary arrhythmia dynamics categories as well as normal cardiac excitation-contraction coupling.",
keywords = "Ca signaling, Fibrillation, Nonlinear dynamics, Reentry, Repolarization reserve, Sudden cardiac death",
author = "Weiss, {James N.} and Alan Garfinkel and Karagueuzian, {Hrayr S.} and Nguyen, {Thao P.} and Riccardo Olcese and Peng-Sheng Chen and Zhilin Qu",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.yjmcc.2015.02.017",
language = "English (US)",
volume = "82",
pages = "136--152",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Perspective

T2 - A dynamics-based classification of ventricular arrhythmias

AU - Weiss, James N.

AU - Garfinkel, Alan

AU - Karagueuzian, Hrayr S.

AU - Nguyen, Thao P.

AU - Olcese, Riccardo

AU - Chen, Peng-Sheng

AU - Qu, Zhilin

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Despite key advances in the clinical management of life-threatening ventricular arrhythmias, culminating with the development of implantable cardioverter-defibrillators and catheter ablation techniques, pharmacologic/biologic therapeutics have lagged behind. The fundamental issue is that biological targets are molecular factors. Diseases, however, represent emergent properties at the scale of the organism that result from dynamic interactions between multiple constantly changing molecular factors. For a pharmacologic/biologic therapy to be effective, it must target the dynamic processes that underlie the disease. Here we propose a classification of ventricular arrhythmias that is based on our current understanding of the dynamics occurring at the subcellular, cellular, tissue and organism scales, which cause arrhythmias by simultaneously generating arrhythmia triggers and exacerbating tissue vulnerability. The goal is to create a framework that systematically links these key dynamic factors together with fixed factors (structural and electrophysiological heterogeneity) synergistically promoting electrical dispersion and increased arrhythmia risk to molecular factors that can serve as biological targets. We classify ventricular arrhythmias into three primary dynamic categories related generally to unstable Ca cycling, reduced repolarization, and excess repolarization, respectively. The clinical syndromes, arrhythmia mechanisms, dynamic factors and what is known about their molecular counterparts are discussed. Based on this framework, we propose a computational-experimental strategy for exploring the links between molecular factors, fixed factors and dynamic factors that underlie life-threatening ventricular arrhythmias. The ultimate objective is to facilitate drug development by creating an in silico platform to evaluate and predict comprehensively how molecular interventions affect not only a single targeted arrhythmia, but all primary arrhythmia dynamics categories as well as normal cardiac excitation-contraction coupling.

AB - Despite key advances in the clinical management of life-threatening ventricular arrhythmias, culminating with the development of implantable cardioverter-defibrillators and catheter ablation techniques, pharmacologic/biologic therapeutics have lagged behind. The fundamental issue is that biological targets are molecular factors. Diseases, however, represent emergent properties at the scale of the organism that result from dynamic interactions between multiple constantly changing molecular factors. For a pharmacologic/biologic therapy to be effective, it must target the dynamic processes that underlie the disease. Here we propose a classification of ventricular arrhythmias that is based on our current understanding of the dynamics occurring at the subcellular, cellular, tissue and organism scales, which cause arrhythmias by simultaneously generating arrhythmia triggers and exacerbating tissue vulnerability. The goal is to create a framework that systematically links these key dynamic factors together with fixed factors (structural and electrophysiological heterogeneity) synergistically promoting electrical dispersion and increased arrhythmia risk to molecular factors that can serve as biological targets. We classify ventricular arrhythmias into three primary dynamic categories related generally to unstable Ca cycling, reduced repolarization, and excess repolarization, respectively. The clinical syndromes, arrhythmia mechanisms, dynamic factors and what is known about their molecular counterparts are discussed. Based on this framework, we propose a computational-experimental strategy for exploring the links between molecular factors, fixed factors and dynamic factors that underlie life-threatening ventricular arrhythmias. The ultimate objective is to facilitate drug development by creating an in silico platform to evaluate and predict comprehensively how molecular interventions affect not only a single targeted arrhythmia, but all primary arrhythmia dynamics categories as well as normal cardiac excitation-contraction coupling.

KW - Ca signaling

KW - Fibrillation

KW - Nonlinear dynamics

KW - Reentry

KW - Repolarization reserve

KW - Sudden cardiac death

UR - http://www.scopus.com/inward/record.url?scp=84925127686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925127686&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2015.02.017

DO - 10.1016/j.yjmcc.2015.02.017

M3 - Article

VL - 82

SP - 136

EP - 152

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

ER -